RAB22A and hepatocellular carcinoma: In another study, RAB22A was significantly up-regulated in hepatocellular carcinoma, which was significantly related to the infiltration of various immune cells and the gene expression of immune checkpoints, and may lead to poor prognosis of hepatocellular carcinoma by regulating immune function [13].